Clinical Efficacy of Belotecan (CKD-602), Newly Developed Camptothecin Analog, in the 2nd Line Treatment of Relapsed Small Cell Lung Cancer.

Author: Hee Jung BAN ¹ ; In Jae OH ; Kyu Sik KIM ; Jin Yung JU ; Yong Soo KWON ; Yu Il KIM ; Sung Chul LIM ; Young Chul KIM
Author Information

1. Lung and Esophageal Cancer Clinic, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Korea. cyberkks@chonnam.ac.kr
Publication Type:Original Article
Keywords: Belotecan; Camptothecin; Small cell lung carcinoma; Relapse
MeSH: Camptothecin; Recurrence; Small Cell Lung Carcinoma
From:Tuberculosis and Respiratory Diseases 2009;66(2):93-97
CountryRepublic of Korea
Language:English
Abstract: No abstract available.